In addition, PRKN immune modulation was specific for tumor-bearing mice because PRKN-KO mice showed no significant changes in lymphoid or myeloid splenocytes at 26 weeks of age compared with WT C57BL/6J mice (Supplemental Figure 6E). The gene discussed is PRKN; the disease is neoplasm.